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Chemokines are low molecular mass cytokine-like proteins
that orchestrate myriads of immune functions like leukocyte
trafficking, T cell differentiation, angiogenesis, hematopeo-
sis and mast cell degranulation. Chemokines also play a
role as HIV-1 inhibitor and act as potent natural adjuvant
in antitumor immunotherapy. Receptors for these mol-
ecules are all seven-pass transmembrane G-protein-coupled
receptors that are intimately involved with chemokines in a
wide array of physiological and pathological conditions.
These receptors also have a major role as co-receptors for
HIV-1 entry into target cells. Therefore, chemokine recep-
tors have proven to be excellent targets for small molecule
in pharmaceutical industry. The immense importance of
chemokines and their receptors motivated us to develop a
support vector machine-based method ChemoPred to
predict this important class of proteins and further classify
them into subfamilies. ChemoPred is capable of predicting
chemokines and chemokine receptors with an accuracy of
95.08% and 92.19%, respectively. The overall accuracy of
classification of chemokines into three subfamilies was
96.00% and that of chemokine receptors into three families
was 92.87%. The server ChemoPred is freely available at
www.imtech.res.in/raghava/chemopred.
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Introduction
Chemokines are small protein sequences that are important
components of innate immune system and are believed to
regulate leukocyte trafficking during normal physiological
processes and pathological conditions. Chemokines are large
peptides, 70–125 amino acids in length, and are rich in basic
amino acid residues. On the basis of the number and spacing
of conserved cysteine residues that they contain, chemokines
are further divided into four subfamilies (Rossi and Zlotnik,
2000) viz CXC or alpha chemokines, CC or beta chemokines,
C or gamma chemokine and CX3C or delta chemokines.
Chemokines were named so due to their chemoattractant
properties that were first demonstrated in a chemotaxis assay
for neutrophils (Yoshimura et al., 1987). It has been now
shown that chemokine has a role to play in leukocyte
trafficking (Yoshimura et al., 1987; Cyster, 1999; Peveri
et al., 1999), hematopoeisis (Cook, 1996; Quackenbush
et al., 1997; Kim and Broxmeyer, 1999), organogenesis
(Ma et al., 1998), neuronal communication (Harrison et al.,
1998) and modulate angiogenesis (Moore et al., 1998). They
are also suggested to act as inflammatory mediators (Gura,
1996; Luster, 1998). Some chemokines can function as
inhibitors of HIV-1 (Cocchi et al., 1995). Chemokines are
also proposed to act as potent natural adjuvants for antitumor
immunotherapy (Narvaiza, 2000; Ruehlmann et al., 2001).
Chemokines bind to a set of receptors called chemokine
receptors to perform all these vital functions. Engagement of
chemokine receptors by appropriate chemokines leads to a
cascade of downstream signaling event that ultimately results
in the functions performed by chemokines as mentioned
above. These receptors are a seven-pass transmembrane
receptor proteins belonging to a subfamily of G-protein-
coupled receptor (Rojo et al., 1999; Sallusto et al., 2000;
Thelen, 2001). Like their ligands (i.e. the chemokines), che-
mokine receptors are also further subdivided into four subfa-
milies, i.e. CXCR, CCR, CR and CX3CR, based upon their
primary amino acid sequence. Chemokines and chemokine
receptors are intimately involved in a wide array of diseases
(Sallusto et al., 1998; Zlotnik et al., 1999). Potent chemokine
receptor agonists may, therefore, be useful to treat varied
conditions such as inflammation and neoplasia. With the dis-
covery of the fact that some chemokine receptors act as
co-receptors for HIV entry into target cells (Alkhatib et al.,
1996; Choe et al., 1996; Deng et al., 1996; Doranz et al.,
1996; Dragic et al., 1996), research has really been acceler-
ated to find small chemicals that can block these receptors
and thereby HIV entry into the target cells. Therefore, these
receptors are considered to be of prime importance as poten-
tial drug target by the pharmaceutical industry.
Advances over the past few years have included the discov-
ery of new chemokines, receptors and antagonists, and a
greater appreciation for the diverse biological functions dis-
played by this cytokine family. Keeping in mind such diverse
roles played by the chemokines and their receptors, identifi-
cation of these would enable us to dissect the complex reactions
and to advance our knowledge on how an immune system is
operated. A large amount of sequence data are piling up with
the completion of ongoing genome-sequencing projects, but
the functional class of several proteins still remains unclear.
Thus, computer-aided prediction of chemokines and chemo-
kine receptors from a large amount of sequence data whose
function is still largely unknown would be very fruitful for biol-
ogists as the experimental determination of the functions would
be a laborious and time-consuming job. In this paper, an
attempt has been made to achieve to predict and classify che-
mokines and chemokine receptors. A support vector machine
(SVM)-based approach was adopted in order to predict and
further classify further them into subfamilies.
Methods
Data sets
Positive data set The positive data sets for both chemokines
and chemokine receptors were downloaded from http://
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cytokine.medic.kumamoto-u.ac.jp/. Chemokine data set had
431 protein sequences, whereas the data set for chemokine
receptor had 314 protein sequences. CD-HIT software (Li
and Godzik, 2006) was used to remove sequences that are
highly homologous from these data sets, the cut-off being
90%. Thus, no two sequences in the data sets were .90%
similar, and hence, the data sets used are non-redundant.
After using CD-HIT, 193 chemokine and 96 chemokine
receptor sequences were left in the data sets. These data sets
(as appear in the respective order) were used as positive data
sets for developing the method.
Negative data set A systematic approach was adopted to
select the negative data sets to be used for training the
method. Protein sequences were retrieved from UniProt
(Apweiler et al., 2004) using the mammalian proteins
‘BUTNOT chemokines’ criteria. Now a BLAST (Altschul
et al., 1990) search was performed against the database of
these sequences for each and every protein in the positive
data set. The result obtained was sequences that were hom-
ologous to chemokines but were performing different func-
tion. One hundred and ninety-three proteins were selected
from the resulting sequences. These were used as negative
data set against chemokines. Similar strategy was used to get
96 protein sequences to be used as negative data set against
the positive chemokine receptors.
Prediction
The data set for chemokine prediction contained a total of
386 sequences (193 positive and 193 negative examples),
whereas that for the chemokine receptor prediction contained
a total of 192 sequences (96 positive and 96 negative).
Amino acid compositions of the sequences were given as the
input pattern to train the SVM. For evaluating and develop-
ing the method, a cut-off value was chosen where the sensi-
tivity and specificity were nearly equal or the difference
between them is the least.
Evaluation of the models was done using 5-fold cross-
validation technique. The data were randomly divided into
five sets, each set containing almost equal number of
examples. The method was trained on four sets and tested on
the remaining one set. This was repeated five times, so that
each set was used once as test set.
We adopted another strategy for evaluating the perform-
ance of the method. We randomly picked 20% of the data set
as the testing set and the remaining data set was used as the
training set to train the model. This procedure was repeated
100 times and the results obtained in each cycle were aver-
aged to get the final result.
Classification
Chemokine classification The data set contains sequences
from four major families of chemokines containing about
five C family sequences, 109 CC family sequences, 76 CXC
family sequences and four CX3C family sequences.
Therefore, a prediction method to classify the chemokines
into families was also developed. As the number of
sequences in C and CX3C families was not enough, these
were clubbed together to form a single class called ‘joint
class’. Thus, the method was developed to predict three
families of chemokines instead of four. For family classifi-
cation, the data set consisted of 193 chemokine sequences
only. As it is multi-class prediction problem, we developed a
series of classifiers to handle the problem. N SVMs were
constructed for N-class classification. For chemokine family
classification, the number of classes was equal to 3. The ith
SVM was trained with all the samples of ith class labeled
positive and all other samples labeled negative. An unknown
example was classified into the class that corresponds to the
SVM with the highest output score. The results for the
family prediction are given in Table I.
Chemokine receptor classification The data set for chemo-
kine receptors contained 96 sequences belonging to four
families. These include five examples from CR family, 58
examples from CCR family, 29 examples from CXCR
family and four examples from CX3CR family. As the
number of sequences in CR and CX3CR families was very
few, they were combined into a single family called joint
class. Then, N SVMs were constructed as described in che-
mokine classification case. For chemokine receptor family
classification, the number of classes was equal to 3. The ith
SVM was trained with all the samples of ith class labeled
positive and all other samples labeled negative. An unknown
example was classified into the class that corresponds to the
SVM with the highest output score. The results for the
family prediction are given in Table I.
Support vector machine
In this study, all SVM models have been developed using a
freely available program SVM_LIGHT (Joachims, 1999).
This program allows users to run SVM using various kernels
and parameters. In this study, the accuracy was computed at
a cut-off score where sensitivity and specificity are nearly
equal.
Evaluation parameters
The evaluation of performance of the method was done by
calculating the sensitivity, specificity, accuracy and the
Methew’s correlation coefficient (MCC) of the prediction.
Sensitivity is the percentage of positive examples (chemo-
kines or chemokine receptors in this case), which are correctly
predicted as positive. Specificity is the percentage of negative
examples (non-chemokines or non-chemokine receptors in
this case), which are correctly predicted to be negative.
Accuracy is the percentage of correctly predicted positive and
negative examples. It is a good measure to assess the perform-
ance of any method when the data set is balanced (equal
number of positive and negative examples). It is also known
as percent coverage. The formulae for calculating these par-
ameters are as follows:
Sensitivity ¼ TP
TPþ FN 100
Specificity ¼ TN
TNþ FP 100
Accuracy ¼ TPþ TN
TPþ TNþ FPþ FN 100
MCC ¼ TP TN FP FNffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi½ðTPþ FNÞðTNþ FPÞðTPþ FPÞðTNþ FNÞp 
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where, TP is true positive; TN, true negative; FP, false posi-
tive and FN, false negative.
Results and discussions
Chemokines and chemokine receptors are an important
class of innate immunity molecules. To the best of author’s
knowledge, this is the first method to predict and classify
chemokine and their receptors. Although methods have
been developed earlier to predict and classify cytokines
(Huang et al., 2005; Lata and Raghava, 2008) and some
receptors such as nuclear receptor (Bhasin and Raghava,
2004) and GPCR (Bhasin and Raghava, 2004), no such
method is present for chemokines and their receptors. In
this method, we adopted a systematic strategy to select the
negative data set rather than selecting some random
sequences as negative examples as selection of negative
data set is always a challenge for any study. In order to
minimize error in our negative examples, we selected nega-
tive examples/proteins only from Swiss-Prot (a database of
annotated proteins). In other words, function of these pro-
teins is known and it is not chemokines as per Swiss-Prot.
Despite our careful selection of negative examples, it is
still possible that some of negative examples may have che-
mokines. During creation of negative data set using
BLAST, we cautiously removed the examples that by any
chance happened to be the chemokines or chemokine
receptors. This was done in order to lessen the bias in the
method had the random sequences (which may be distantly
remote and easily distinguishable) been used.
ChemoPred achieved an accuracy of 95.08% for chemo-
kine prediction and 92.16% for chemokine receptor predic-
tion using 5-fold cross-validation technique. The sensitivity
and specificity achieved for chemokine prediction were
94.82% and 95.34%, respectively. The sensitivity and speci-
ficity for chemokines receptor prediction were 90.62% and
93.75%, respectively. We also plotted the sensitivity versus
1-specificity chart, i.e. receiver operator curve (ROC), from
the prediction methods. The area under curve for chemokine
prediction was 0.987 (Fig. 1) and that for their receptor pre-
diction was 0.906 (Fig. 2).
On using the random samplings evaluation technique, the
sensitivity, specificity and accuracy achieved for chemokines
were 95.82, 95.84 and 95.44, respectively. For chemokine
receptors, the sensitivity, specificity and accuracy achieved
using this technique were 88.63, 92.98 and 90.55,
respectively.
An attempt was made to further classify the chemokines
and chemokine receptors into subfamilies. The amino acid
composition-based chemokine subfamily classification
(using 5-fold cross-validation technique) achieved an
overall accuracy of 97.02% and an average MCC of 0.95.
The overall accuracy and average MCC obtained in chemo-
kine receptor subfamily classification were 90.17% and
0.92 (Table I).
ChemoPred can predict as well as classify a chemokine
protein with high accuracy as well as with high sensitivity
and specificity. We hope that our method would be of
great help in order to annotate the proteins and would aid
the experimental validation, in turn, saving time and
labor.
Table I. Performance of method ChemoPred for chemokine and its receptors subfamily classification
Chemokine Chemokine receptors
Sensitivity Specificity Accuracy MCC Sensitivity Specificity Accuracy MCC
Joint class 100.00% 100.00% 100.00% 1.00 100.00% 100.00% 100.00% 1.00
CC 97.25% 96.43% 96.89% 0.94 94.83% 94.74% 94.79% 0.89
CXC 96.05% 97.44% 96.89% 0.93 93.10% 95.52% 94.79% 0.88
Fig. 1. ROC curve for chemokine prediction.
Fig. 2. ROC curve for chemokine receptor prediction.
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Webserver
All the modules constructed in this study have been
implemented on the World Wide Web as a dynamic webser-
ver ‘ChemoPred’ which is available freely at
www.imtech.res.in/raghava/chemopred. All the scripts of the
method were written in CGI-PERL and the interface was
designed using HTML. It is a user-friendly webserver that
allows the users to submit their query sequence by typing or
pasting it in the box or by using the file upload facility. The
user can choose if they want to go for chemokine prediction
or chemokine receptor prediction in the submission form.
The result of predicted superfamily and subfamily of the
query protein is displayed in a user-friendly tabular format.
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